866-997-4948(US-Canada Toll Free)

Veterinary Vaccines Market: Greater Adoption of Live Attenuated Vaccines Likely to be Witnessed Throughout the Forecast Period: Middle East Industry Analysis & Opportunity Assessment, 2016 - 2026

Published By :

Future Market Insights

Published Date : Mar 2017

Category :

Vaccines

No. of Pages : 176 Pages

Attenuated live vaccines are expected to emerge as the dominant vaccine type segment over the forecast period

Attenuated live vaccines segment is the largest segment among the vaccine type segments, which was estimated to create close to US$ 90 Mn, or more than 30% share of the total market in 2016. By the end of 2026, attenuated live vaccines segment is projected to reach more than US$ 150 Mn, expanding at a CAGR of 5.8% over the forecast period. Greater adoption of live attenuated vaccines is expected to contribute to the attractive absolute $ opportunity of the segment. Attenuated live vaccines segment is expected to be the most lucrative in the MEA veterinary vaccines market with a market attractiveness index of 2.0.

Rising incidence of food borne and zoonotic diseases in MEA countries likely to fuel the demand for attenuated live vaccines

Rising incidence of food borne and zoonotic diseases in MEA countries is fuelling the demand in the attenuated live vaccines segment in the region. As the pattern of veterinary treatment is shifting from curative/reactive to preventive, the cost of a preventive treatment is much smaller and has far less side effects than reactive treatments that often lead to mass slaughter. This is the precise reason behind driving the growth of the attenuated live vaccines segment in the MEA region. Rebound of economic prosperity in MEA markets is expected to contribute towards increased demand for processed healthy meat products. This demands effective vaccination of livestock, especially in major animal farming and meat producing nations with a diversified herd in the region such as Sudan, Turkey, Egypt and KSA. Rising per capita disposable income levels are largely contributing to the rise in demand for processed food items. This is expected to drive the growth in demand for attenuated live vaccines in the poultry and livestock segments.

There are international guidelines on the usage of livestock identification and traceability systems (LITS) for better herd management, identifying zoonosis and managing animal health and incorporating food safety. However, most countries in the MEA region fail to implement proper LITS thereby affecting effective animal disease management. This is expected to fuel the demand for protective maintenance of animal health through early attenuated live vaccinations in order to avoid the spread of infectious diseases. The countries within the MEA region and Central Europe are increasingly dependent on live stock trading as a means of survival. Furthermore, in order to address chronic food insecurity in rural areas, animals are transferred from one place to another. This is fuelling demand for adequate vaccinations as an infection affecting one of the herds could easily spread to another and lead to mass losses. This factor is creating a positive impact on attenuated live vaccinations in the region.

Attenuated live vaccines are expected to witness increased demand throughout the forecast period in Jordan

The attenuated live vaccines segment is expected to witness a significant CAGR given greater adoption in commercial farms in the UAE veterinary vaccines market. Lower dosages and repetition are factors that are expected to contribute towards greater demand for attenuated live vaccines among all animal segments in Turkey. In Jordan, attenuated live vaccines are expected to witness increased demand throughout the forecast period. Lack of organised animal rearing and tracking practices hinder estimation of demand for attenuated live vaccines in Sudan.

Scenario of Local Manufacturing and Veterinary Vaccine Registration

The MEA region accounts for a vast livestock population; however, it is largely dependent on imports for the supply of adequate veterinary vaccines. Only six countries have the facility to produce vaccines locally. These include Egypt, Jordan, Saudi Arabia, Sudan, Syria and Turkey. Local produce acceptance is higher as regulatory authorities have relatively fewer requirements for local vaccines than imported ones. The time duration for imported vaccines to obtain the required registration is also longer. Only four countries follow the international norms of OIE although the OIE has not yet established official international standards in this respect.

--- Analyst Healthcare, Pharmaceuticals and Medical Devices, Future Market Insights

Table Of Content


1. Executive Summary


2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
2.3. Parent / Associated Market Overview


3. Middle East Veterinary Vaccines Market Analysis Scenario
3.1. Market Size (US$ Mn) and Forecast
3.1.1. Market Size and Y-o-Y Growth
3.1.2. Absolute $ Opportunity
3.2. Market Overview
3.2.1. Value Chain


4. Market Dynamics and USPs
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
4.5.Standard Approval Process U.S.
4.6.Vaccines Labelling Requirements
4.7.Scenario of Local Manufacturing and Veterinary Vaccine Registration
4.8.Veterinary Medical Product Registration Timelines and Products


5. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Vaccine Type
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Vaccine Type
5.3. Y-o-Y Growth Projections By Vaccine Type
5.4. Market Value Forecast By Vaccine Type, 20162026
5.4.1. Live Attenuated Vaccines
5.4.2. Killed/Inactive Vaccines
5.4.3. Recombinant Vaccines
5.4.4. DNA Vaccines
5.4.5. Toxoid Vaccines
5.4.6. Others
5.5. Market Attractiveness By Vaccine Type


6. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Animal Type
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By Animal Type
6.3. Y-o-Y Growth Projections By Animal Type
6.4. Market Value Forecast By Animal Type, 20162026
6.4.1. Companion Animal
6.4.1.1. Canine
6.4.1.2. Feline
6.4.1.3. Avian (Ornamental Bird)
6.4.2. Livestock Animal
6.4.2.1. Aquatic
6.4.2.2. Bovine
6.4.2.3. Porcine
6.4.2.4. Small Ruminant
6.4.2.5. Poultry
6.4.3. Equine
6.5. Market Attractiveness By Animal Type


7. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Disease Indication
7.1. Introduction
7.2. Basis Point Share (BPS) Analysis By Disease Indication
7.3. Y-o-Y Growth Projections By Disease Indication
7.4. Market Value Forecast By Disease Indication, 20162026
7.4.1. Foot and Mouth Diseases
7.4.2. Avian Influenza
7.4.3. New Castle Disease
7.4.4. PPRS
7.4.5. Brucellosis
7.4.6. Canine Parvovirus
7.4.7. Others
7.5. Market Attractiveness By Disease Indication


8. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Distribution Channel
8.1. Introduction
8.2. Basis Point Share (BPS) Analysis By Distribution Channel
8.3. Y-o-Y Growth Projections By Distribution Channel
8.4. Market Value Forecast By Distribution Channel, 20162026
8.4.1. Hospital Pharmacies
8.4.2. Veterinary Clinics
8.4.3. Private Veterinary Pharmacies
8.4.4. Others ( Research Institutes, Laboratories)
8.5. Market Attractiveness By Distribution Channel


9. Middle East Veterinary Vaccines Market Analysis and Forecasts, By Country
9.1. Basis Point Share (BPS) Analysis By Country
9.2. Y-o-Y Growth Projections By Country
9.3. Market Value Forecast By Country
9.3.1. UAE
9.3.2. KSA
9.3.3. Turkey
9.3.4. Jordan
9.3.5. Sudan
9.3.6. Egypt
9.3.7. Rest of MEA
9.4. Market Attractiveness By Country


10. UAE Veterinary Vaccines Market Analysis and Forecast
10.1.Market Value Forecast By Vaccine Type, 20162026
10.1.1. Live Attenuated Vaccines
10.1.2. Killed/Inactive Vaccines
10.1.3. Recombinant Vaccines
10.1.4. DNA Vaccines
10.1.5. Toxoid Vaccines
10.1.6. Others
10.2.Market Value Forecast By Disease Indication, 20162026
10.2.1. Foot and Mouth Diseases
10.2.2. Avian Influenza
10.2.3. New Castle Disease
10.2.4. PPRS
10.2.5. Brucellosis
10.2.6. Canine Parvovirus
10.2.7. Others
10.3.Market Value Forecast By Animal Type, 20162026
10.3.1. Companion Animal
10.3.1.1. Canine
10.3.1.2. Feline
10.3.1.3. Avian (Ornamental Bird)
10.3.2. Livestock Animal
10.3.2.1. Aquatic
10.3.2.2. Bovine
10.3.2.3. Porcine
10.3.2.4. Small Ruminant
10.3.2.5. Poultry
10.3.3. Equine
10.4.Market Value Forecast By Distribution Channel, 20162026
10.4.1. Hospital Pharmacies
10.4.2. Veterinary Clinics
10.4.3. Private Veterinary Pharmacies
10.4.4. Others ( Research Institutes, Laboratories)


11. KSA Veterinary Vaccines Market Analysis and Forecast
11.1.Market Value Forecast By Vaccine Type, 20162026
11.1.1. Live Attenuated Vaccines
11.1.2. Killed/Inactive Vaccines
11.1.3. Recombinant Vaccines
11.1.4. DNA Vaccines
11.1.5. Toxoid Vaccines
11.1.6. Others
11.2.Market Value Forecast By Disease Indication, 20162026
11.2.1. Foot and Mouth Diseases
11.2.2. Avian Influenza
11.2.3. New Castle Disease
11.2.4. PPRS
11.2.5. Brucellosis
11.2.6. Canine Parvovirus
11.2.7. Others
11.3.Market Value Forecast By Animal Type, 20162026
11.3.1. Companion Animal
11.3.1.1. Canine
11.3.1.2. Feline
11.3.1.3. Avian (Ornamental Bird)
11.3.2. Livestock Animal
11.3.2.1. Aquatic
11.3.2.2. Bovine
11.3.2.3. Porcine
11.3.2.4. Small Ruminant
11.3.2.5. Poultry
11.3.3. Equine
11.4.Market Value Forecast By Distribution Channel, 20162026
11.4.1. Hospital Pharmacies
11.4.2. Veterinary Clinics
11.4.3. Private Veterinary Pharmacies
11.4.4. Others ( Research Institutes, Laboratories)
12. Turkey Veterinary Vaccines Market Analysis and Forecast
12.1.Market Value Forecast By Vaccine Type, 20162026
12.1.1. Live Attenuated Vaccines
12.1.2. Killed/Inactive Vaccines
12.1.3. Recombinant Vaccines
12.1.4. DNA Vaccines
12.1.5. Toxoid Vaccines
12.1.6. Others
12.2.Market Value Forecast By Disease Indication, 20162026
12.2.1. Foot and Mouth Diseases
12.2.2. Avian Influenza
12.2.3. New Castle Disease
12.2.4. PPRS
12.2.5. Brucellosis
12.2.6. Canine Parvovirus
12.2.7. Others
12.3.Market Value Forecast By Animal Type, 20162026
12.3.1. Companion Animal
12.3.1.1. Canine
12.3.1.2. Feline
12.3.1.3. Avian (Ornamental Bird)
12.3.2. Livestock Animal
12.3.2.1. Aquatic
12.3.2.2. Bovine
12.3.2.3. Porcine
12.3.2.4. Small Ruminant

 

List of Table

Table 1: Middle East Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026
Table 2: Middle East Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026
Table 3: Middle East Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026
Table 4: Middle East Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026
Table 5: Middle East Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2026
Table 6: UAE Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026
Table 7: UAE Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026
Table 8: UAE Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026
Table 9: UAE Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026
Table 10: KSA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026
Table 11: KSA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026
Table 12: KSA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026
Table 13: KSA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026
Table 14: Turkey Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026
Table 15: Turkey Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026
Table 16: Turkey Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026
Table 17: Turkey Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026
Table 18: Jordan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026
Table 19: Jordan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026
Table 20: Jordan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026
Table 21: Jordan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026
Table 22: Sudan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026
Table 23: Sudan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026
Table 24: Sudan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026
Table 25: Sudan Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026
Table 26: Egypt Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026
Table 27: Egypt Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026
Table 28: Egypt Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026
Table 29: Egypt Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026
Table 30: Rest of MEA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Vaccine Type, 2015 – 2026
Table 31: Rest of MEA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2015 – 2026
Table 32: Rest of MEA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015 – 2026
Table 33: Rest of MEA Veterinary Vaccines Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2026

List of Chart

Figure 01: Middle East Veterinary Vaccines Market Value (US$ Mn) Forecast 2016 and 2026
Figure 02: Middle East Veterinary Vaccines Market Value Share, By Vaccine Type, 2016
Figure 03: Middle East Veterinary Vaccines Market Value Share, By Animal Type, 2016
Figure 04: Middle East Veterinary Vaccines Market Value Share, By Disease Indication, 2016
Figure 05: Middle East Veterinary Vaccines Market Value Share, By End User, 2016
Figure 06: Middle East Veterinary Vaccines Market Value Share, By Country, 2016
Figure 07: Middle East Veterinary Vaccines Market Value (US$ Mn) Forecast, 2015–2026 
Figure 08: Middle East Veterinary Vaccines Market Absolute $ Opportunity, 2015–2026 
Figure 09: Middle East Veterinary Vaccines Market Y-o-Y Growth, 2015–2026 
Figure 10: Middle East Veterinary Vaccines Market Share Analysis (%) By Vaccine Type, 2016 & 2026
Figure 11: Middle East Veterinary Vaccines Market Y-o-Y Growth (%) By Vaccine Type, 2015–2026 
Figure 12: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Attenuated Live Vaccines Segment, 2015 – 2026
Figure 13: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Inactivated Vaccines Segment, 2015 – 2026
Figure 14: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Toxoid Vaccine Segment, 2015 – 2026
Figure 15: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By DNA Vaccine Segment, 2015 – 2026
Figure 16: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) Recombinant Vaccines s Segment, 2015 – 2026
Figure 17: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2015 – 2026
Figure 18: Middle East Veterinary Vaccines Market Attractiveness Analysis By Vaccine Type, 2016–2026 
Figure 19: Middle East Veterinary Vaccines Market Share Analysis (%) By Animal Type, 2016 & 2026
Figure 20: Middle East Veterinary Vaccines Market Y-o-Y Growth (%) By Animal Type, 2015–2026 
Figure 21: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Companion Animals Segment, 2015 – 2026
Figure 22: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Livestock Animals Segment, 2015 – 2026
Figure 23: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Equine Segment, 2015 – 2026
Figure 24: Middle East Veterinary Vaccines Market Attractiveness Analysis By Animal Type, 2016–2026 
Figure 25: Middle East Veterinary Vaccines Market Share Analysis (%) By Disease Indication, 2020 & 2026
Figure 26: Middle East Veterinary Vaccines Market Y-o-Y Growth (%) By Disease Indication, 2015–2026 
Figure 27: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Foot and Mouth Disease  Segment, 2015 – 2026
Figure 28: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By New Castle Disease Segment, 2015 – 2026
Figure 29: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By PPRS Segment, 2015 – 2026
Figure 30: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Canine Parvovirus Segment, 2015 – 2026
Figure 31: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Brucellosis Segment, 2015 – 2026
Figure 32: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Avian Influenza Segment, 2015 – 2026
Figure 33: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2015 – 2026
Figure 34: Middle East Veterinary Vaccines Market Attractiveness Analysis By Disease Indication, 2016–2026 
Figure 35: Middle East Veterinary Vaccines Market Share Analysis (%) By End User, 2020 & 2026
Figure 36: Middle East Veterinary Vaccines Market Y-o-Y Growth (%) By End User, 2015–2026 
Figure 37: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Hospital Pharmacies Segment, 2015 – 2026
Figure 38: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Veterinary Clinics  Segment, 2015 – 2026
Figure 39: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Private Veterinary Pharmacies  Segment, 2015 – 2026
Figure 40: Middle East Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2015 – 2026
Figure 41: Middle East Veterinary Vaccines Market Attractiveness Analysis By End User, 2016–2026 
Figure 42: Middle East Veterinary Vaccines Market Share Analysis (%) By Country, 2016 & 2026
Figure 43: Middle East Veterinary Vaccines Market Y-o-Y Growth (%) By Country, 2015–2026 
Figure 44: UAE Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn),
Figure 45: KSA Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn),
Figure 46: Turkey Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 47: Jordan Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 48: Sudan Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 49: Egypt Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 50: Rest of MEA
Figure 51: Middle East Veterinary Vaccines Market Attractiveness Analysis By Country, 2016–2026 

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *